IPQ Inside the global regulatory dialogue

Improving Communications on Drug/Device Combination Product Quality and Performance is an Increasing Priority in the US and Europe

May 10th, 2018

Please Log in to print the full article

New terminology is emerging to strengthen the bridge – for example, “essential performance” from FDA – but more definitional clarity is needed to facilitate industry implementation. Traditionally, drug manufacturers may have viewed pre-filled syringes, for...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2021 IPQ Publications